Tibor T Glant Selected Research

Proteoglycans (Proteoglycan)

5/2021	Vaccination by Two DerG LEAPS Conjugates Incorporating Distinct Proteoglycan (PG, Aggrecan) Epitopes Provides Therapy by Different Immune Mechanisms in a Mouse Model of Rheumatoid Arthritis.
1/2020	Regulation of autoimmune arthritis by the SHP-1 tyrosine phosphatase.
1/2019	Amelioration of Autoimmune Arthritis in Mice Treated With the DNA Methyltransferase Inhibitor 5'-Azacytidine.
1/2017	An epitope-specific DerG-PG70 LEAPS vaccine modulates T cell responses and suppresses arthritis progression in two related murine models of rheumatoid arthritis.
1/2017	Early anti-inflammatory intervention ameliorates axial disease in the proteoglycan-induced spondylitis mouse model of ankylosing spondylitis.
1/2016	Inflammation-driven bone formation in a mouse model of ankylosing spondylitis: sequential not parallel processes.
1/2016	Immune Recognition of Citrullinated Proteoglycan Aggrecan Epitopes in Mice with Proteoglycan-Induced Arthritis and in Patients with Rheumatoid Arthritis.
11/2015	Treatment of a mouse model of ankylosing spondylitis with exogenous sclerostin has no effect on disease progression.
2/2014	Brief report: Autologous stem cell transplantation restores immune tolerance in experimental arthritis by renewal and modulation of the Teff cell compartment.
1/2014	Suppression of proteoglycan-induced autoimmune arthritis by myeloid-derived suppressor cells generated in vitro from murine bone marrow.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tibor T Glant Research Topics

Disease

62	Arthritis (Polyarthritis) 05/2021 - 01/2002
33	Rheumatoid Arthritis 05/2021 - 06/2002
19	Inflammation (Inflammations) 01/2017 - 08/2002
10	Experimental Arthritis 02/2014 - 06/2002
8	Spondylitis 01/2017 - 08/2005
5	Disease Progression 01/2019 - 11/2012
3	Autoimmune Diseases (Autoimmune Disease) 06/2015 - 03/2005
3	Osteoarthritis 07/2012 - 07/2003
3	Osteosarcoma (Osteogenic Sarcoma) 04/2006 - 05/2002
2	Uveitis 03/2012 - 01/2012
2	Spondylarthritis (Spinal Arthritis) 03/2012 - 08/2003
2	Skin Diseases (Skin Disease) 04/2011 - 04/2011
2	Bone Resorption 08/2008 - 10/2006
2	Disease Susceptibility (Diathesis) 07/2008 - 06/2002
2	Peritonitis 09/2004 - 09/2002
1	Ankylosing Spondylitis 01/2017
1	Virus Diseases (Viral Diseases) 09/2016
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 09/2016
1	Myocarditis (Carditis) 09/2016
1	Cardiomyopathies (Cardiomyopathy) 09/2016
1	Heart Failure 09/2016
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 02/2014
1	Ankylosis 11/2012
1	Spondylarthropathies 01/2012
1	Pyoderma Gangrenosum 04/2011
1	Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis) 04/2011
1	Communicable Diseases (Infectious Diseases) 01/2008
1	Leukemia 10/2007

Drug/Important Bio-Agent (IBA)

55	Proteoglycans (Proteoglycan)IBA 05/2021 - 01/2002
17	CytokinesIBA 01/2019 - 01/2002
16	AntigensIBA 01/2019 - 06/2002
14	Aggrecans (Aggrecan)IBA 05/2021 - 01/2003
12	EpitopesIBA 05/2021 - 09/2003
8	AutoantibodiesIBA 01/2019 - 01/2002
7	Peptides (Polypeptides)IBA 05/2021 - 09/2003
7	Interleukin-17 (Interleukin 17)IBA 01/2016 - 08/2008
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 08/2002
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2002
5	LigandsIBA 01/2017 - 01/2005
4	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 09/2003
4	AntibodiesIBA 01/2016 - 01/2003
4	InterleukinsIBA 01/2012 - 01/2005
4	ChemokinesIBA 02/2010 - 04/2006
4	Interleukin-6 (Interleukin 6)IBA 07/2008 - 08/2005
4	L-SelectinIBA 08/2006 - 09/2002
3	EnzymesIBA 01/2020 - 08/2003
3	Immunoglobulin G (IgG)IBA 01/2019 - 01/2002
3	AutoantigensIBA 01/2016 - 08/2006
3	CollagenIBA 10/2013 - 01/2003
3	Interleukin-4 (Interleukin 4)IBA 10/2010 - 08/2005
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2010 - 10/2003
3	Interleukin-8 (Interleukin 8)IBA 10/2007 - 05/2002
2	Collagen Type II (Type II Collagen)IBA 05/2021 - 01/2003
2	Non-Receptor Type 6 Protein Tyrosine PhosphataseIBA 01/2020 - 04/2011
2	VaccinesIBA 01/2017 - 06/2015
2	HLA-DQ8 antigenIBA 09/2016 - 06/2004
2	Pharmaceutical PreparationsIBA 02/2014 - 07/2013
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 04/2013 - 06/2004
2	InterferonsIBA 03/2012 - 10/2010
2	Interferon-gamma (Interferon, gamma)IBA 01/2012 - 03/2007
2	Complementary DNA (cDNA)IBA 04/2011 - 09/2003
2	Interleukin-10 (Interleukin 10)IBA 01/2009 - 01/2003
2	OsteoprotegerinIBA 08/2008 - 10/2007
2	Conditioned Culture MediaIBA 10/2007 - 10/2006
2	Chemokine ReceptorsIBA 12/2006 - 01/2005
2	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 06/2004 - 10/2003
1	regorafenibIBA 01/2020
1	Tyrosine (L-Tyrosine)FDA Link 01/2020
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020
1	MethyltransferasesIBA 01/2019
1	A-Form DNA (A-DNA)IBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 11/2018
1	Fingolimod Hydrochloride (FTY720)FDA Link 09/2016
1	HLA-DR Antigens (HLA-DR)IBA 09/2016
1	Metalloproteases (Metalloproteinases)IBA 01/2016
1	CitrullineIBA 01/2016
1	serum P-component (CIt)IBA 01/2016
1	Arginine (L-Arginine)FDA Link 01/2016
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2016
1	TNF Receptor-Associated Factor 1IBA 10/2013
1	Aurora KinasesIBA 07/2013
1	Aurora Kinase AIBA 07/2013
1	Collagen Type I (Type I Collagen)IBA 11/2012
1	Tolonium Chloride FDA Link 11/2012
1	OsteocalcinIBA 11/2012
1	Lipopolysaccharide ReceptorsIBA 07/2012
1	Toll-Like Receptor 4IBA 07/2012
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2012
1	Toll-Like Receptor 2IBA 07/2012
1	Tryptases (Tryptase)IBA 07/2011
1	Biomarkers (Surrogate Marker)IBA 07/2011
1	Heparin (Liquaemin)FDA LinkGeneric 07/2011
1	Staphylococcal Protein A (Protein A)IBA 07/2011
1	ElementsIBA 04/2011
1	Interleukin-27 (Interleukin 27)IBA 01/2008
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2007
1	RANK LigandIBA 10/2007

Therapy/Procedure

6	Therapeutics 05/2021 - 11/2011
2	Intravenous Injections 09/2004 - 09/2003
1	Stem Cell Transplantation 02/2014